Apyx Medical Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.14, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Apyx Medical in Jun 30 2026 quarter, has decreased to 88 days, compared to 89 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 433 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 999 to 3002.

What is Receivable Turnover Ratio?
What is Apyx Medical Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

APYX Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	21.03 %	9.53 %	8.37 %	-0.31 %	-11.5 %
Y / Y Revenue Change	25.27 %	37.62 %	33.65 %	12.26 %	-3.57 %
Receivable Turnover Ratio (TTM)	4.14	4.11	3.95	3.66	3.55
APYX's Total Ranking	# 3002	# 999	# 839	# 2800	# 1286
Accounts Receivable average collection period days	88	89	92	100	103
Seq. Receivable Change	6.73 %	-23.97 %	29.1 %	15.53 %	-3.41 %
Seq. Revenue Change	16.43 %	-40.37 %	62.63 %	10.95 %	27.91 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 158
Healthcare Sector	# 434
Overall Market	# 3002

Receivable Turnover Ratio Statistics
High	Average	Low
14.8	6.56	1.89
(Jun 30 2015)		(Dec 31 2020)

APYX Company Profile • Back to APYX Efficiency Comparisons • Compare APYX Receivables Turnover Ratio to its Competitors

Financial Statements
Apyx Medical's Accounts Receivable	$ 14 Millions	Visit APYX's Balance sheet
Apyx Medical's Sales TTM	$ 58 Millions	Visit APYX's Income Statement
Sources of APYX's Revenues		Visit APYX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
APYX's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
APYX's Growth Rates	APYX's Roa	APYX's Inventory Turnover Ratio	APYX's Dividend Comparisons
APYX's Profitability Ratios	APYX's Roi	APYX's Asset Turnover Ratio	APYX's Dividend Growth
APYX's Valuation Ratios	APYX's Roe	APYX's Financial Strength Ratios	APYX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Premier Air Charter Holdings Inc	11.72	$ 31.562 Millions	$ 2.692 Millions
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Icu Medical Inc	11.42	$ 2,159.998 Millions	$ 189.166 Millions
National Healthcare Corp	11.40	$ 1,559.020 Millions	$ 136.723 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Vaso Corporation	11.31	$ 80.220 Millions	$ 7.094 Millions
Innoviva Inc	11.22	$ 420.630 Millions	$ 37.491 Millions
Lifeloc Technologies Inc	11.19	$ 9.269 Millions	$ 0.828 Millions
Veracyte Inc	11.07	$ 544.735 Millions	$ 49.194 Millions
International Stem Cell Corporation	10.91	$ 9.514 Millions	$ 0.872 Millions
Caredx Inc	10.81	$ 458.089 Millions	$ 42.359 Millions
C4 Therapeutics Inc	10.65	$ 35.039 Millions	$ 3.290 Millions
Radnet Inc	10.53	$ 2,268.932 Millions	$ 215.450 Millions
Kymera Therapeutics Inc	10.50	$ 105.000 Millions	$ 10.000 Millions
Irhythm Holdings Inc	10.42	$ 825.702 Millions	$ 79.250 Millions
Integrated Biopharma Inc	10.38	$ 42.568 Millions	$ 4.101 Millions
Viemed Healthcare Inc	10.36	$ 301.606 Millions	$ 29.102 Millions
Lensar Inc	10.33	$ 60.264 Millions	$ 5.836 Millions
Immucell Corporation	10.30	$ 29.777 Millions	$ 2.891 Millions
Addus Homecare Corp	10.25	$ 1,475.610 Millions	$ 143.923 Millions
Dariohealth Corp	10.23	$ 21.196 Millions	$ 2.072 Millions
Biodesix Inc	10.21	$ 102.939 Millions	$ 10.081 Millions
Kestra Medical Technologies Ltd	10.00	$ 105.939 Millions	$ 10.590 Millions
United Therapeutics Corporation	9.93	$ 3,154.500 Millions	$ 317.550 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions
Biolife Solutions Inc	9.67	$ 102.718 Millions	$ 10.626 Millions
The Oncology Institute Inc	9.66	$ 587.244 Millions	$ 60.780 Millions
Sharps Technology Inc	9.65	$ 1.960 Millions	$ 0.203 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
Septerna Inc	9.42	$ 98.882 Millions	$ 10.501 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.